These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 14674605)

  • 1. Replicating adenoviruses in cancer therapy.
    Dobbelstein M
    Curr Top Microbiol Immunol; 2004; 273():291-334. PubMed ID: 14674605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer.
    Kirn D
    Oncogene; 2000 Dec; 19(56):6660-9. PubMed ID: 11426652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically modified adenoviruses against gliomas: from bench to bedside.
    Gomez-Manzano C; Yung WK; Alemany R; Fueyo J
    Neurology; 2004 Aug; 63(3):418-26. PubMed ID: 15304571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication.
    Hernandez-Alcoceba R; Pihalja M; Qian D; Clarke MF
    Hum Gene Ther; 2002 Sep; 13(14):1737-50. PubMed ID: 12396626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication-selective oncolytic viruses in the treatment of cancer.
    Everts B; van der Poel HG
    Cancer Gene Ther; 2005 Feb; 12(2):141-61. PubMed ID: 15472714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
    Kim J; Cho JY; Kim JH; Jung KC; Yun CO
    Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas.
    Jiang H; Gomez-Manzano C; Alemany R; Medrano D; Alonso M; Bekele BN; Lin E; Conrad CC; Yung WK; Fueyo J
    Neoplasia; 2005 Jan; 7(1):48-56. PubMed ID: 15720816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
    Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
    Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication.
    Bernt K; Liang M; Ye X; Ni S; Li ZY; Ye SL; Hu F; Lieber A
    J Virol; 2002 Nov; 76(21):10994-1002. PubMed ID: 12368342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering regulatory elements for conditionally-replicative adeno-viruses.
    Haviv YS; Curiel DT
    Curr Gene Ther; 2003 Aug; 3(4):357-85. PubMed ID: 12871022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of adenovirus trans-complementation-mediated gene expression controlled by melanoma-specific TETP promoter in vitro.
    Fontecedro AC; Lutschg V; Eichhoff O; Dummer R; Greber UF; Hemmi S
    Virol J; 2010 Jul; 7():175. PubMed ID: 20670430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.
    Doronin K; Kuppuswamy M; Toth K; Tollefson AE; Krajcsi P; Krougliak V; Wold WS
    J Virol; 2001 Apr; 75(7):3314-24. PubMed ID: 11238857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectively replicating adenoviruses for oncolytic therapy.
    Yoon TK; Shichinohe T; Laquerre S; Kasahara N
    Curr Cancer Drug Targets; 2001 Aug; 1(2):85-107. PubMed ID: 12188883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenoviruses.
    Schierer S; Hesse A; Müller I; Kämpgen E; Curiel DT; Schuler G; Steinkasserer A; Nettelbeck DM
    Int J Cancer; 2008 Jan; 122(1):219-29. PubMed ID: 17764070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway.
    Brunori M; Malerba M; Kashiwazaki H; Iggo R
    J Virol; 2001 Mar; 75(6):2857-65. PubMed ID: 11222711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects.
    Kim J; Kim JH; Choi KJ; Kim PH; Yun CO
    Hum Gene Ther; 2007 Sep; 18(9):773-86. PubMed ID: 17725410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect.
    Harrison D; Sauthoff H; Heitner S; Jagirdar J; Rom WN; Hay JG
    Hum Gene Ther; 2001 Jul; 12(10):1323-32. PubMed ID: 11440625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
    Harada JN; Berk AJ
    J Virol; 1999 Jul; 73(7):5333-44. PubMed ID: 10364280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.